2NY7 image
Entry Detail
PDB ID:
2NY7
Title:
HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2006-11-20
Release Date:
2007-02-06
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.25
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 65 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:ENVELOPE GLYCOPROTEIN GP120
Mutations:M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M
Chain IDs:A (auth: G)
Chain Length:317
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Description:ANTIBODY b12, HEAVY CHAIN
Chain IDs:B (auth: H)
Chain Length:230
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:ANTIBODY b12, LIGHT CHAIN
Chain IDs:C (auth: L)
Chain Length:215
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Ligand Molecules
Primary Citation
Structural definition of a conserved neutralization epitope on HIV-1 gp120.
Nature 445 732 737 (2007)
PMID: 17301785 DOI: 10.1038/nature05580

Abstact

The remarkable diversity, glycosylation and conformational flexibility of the human immunodeficiency virus type 1 (HIV-1) envelope (Env), including substantial rearrangement of the gp120 glycoprotein upon binding the CD4 receptor, allow it to evade antibody-mediated neutralization. Despite this complexity, the HIV-1 Env must retain conserved determinants that mediate CD4 binding. To evaluate how these determinants might provide opportunities for antibody recognition, we created variants of gp120 stabilized in the CD4-bound state, assessed binding of CD4 and of receptor-binding-site antibodies, and determined the structure at 2.3 A resolution of the broadly neutralizing antibody b12 in complex with gp120. b12 binds to a conformationally invariant surface that overlaps a distinct subset of the CD4-binding site. This surface is involved in the metastable attachment of CD4, before the gp120 rearrangement required for stable engagement. A site of vulnerability, related to a functional requirement for efficient association with CD4, can therefore be targeted by antibody to neutralize HIV-1.

Legend

Protein

Chemical

Disease

Primary Citation of related structures